Publications by authors named "Davide Ambrosetti"

Claim this Profile
T
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling.
Giulia Gobbi, Alessandra Grieco, Federica Torricelli, Elisabetta Sauta, Giacomo Santandrea, Davide Carlo Ambrosetti

Cell Death Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer.
Elisabetta Sauta, Francesca Reggiani, Federica Torricelli, Eleonora Zanetti, Elena Tagliavini, Davide Ambrosetti

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.
Francesca Reggiani, Elisabetta Sauta, Federica Torricelli, Eleonora Zanetti, Elena Tagliavini, Davide Ambrosetti

Mol Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy.
Francesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, Davide Carlo Ambrosetti, Valentina Sancisi

Biochim Biophys Acta Rev Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells.
Giulia Gobbi, Benedetta Donati, Italo Faria Do Valle, Francesca Reggiani, Federica Torricelli, Davide Carlo Ambrosetti

Oncogene· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2.
Valentina Sancisi, Greta Gandolfi, Davide Carlo Ambrosetti, Alessia Ciarrocchi

Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tollip is a mediator of protein sumoylation.
Alessia Ciarrocchi, Romina D'Angelo, Chiara Cordiglieri, Ada Rispoli, Spartaco Santi, Davide Ambrosetti

PLoS One· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts.
Davide Ambrosetti, Greg Holmes, Alka Mansukhani, Claudio Basilico

Mol Cell Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum.
Massimo Riccio, Spartaco Santi, Maja Dembic, Rossella Di Giaimo, Elena Cipollini, Davide Ambrosetti

Neurobiol Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms underlying differential responses to FGF signaling.
Lisa Dailey, Davide Ambrosetti, Alka Mansukhani, Claudio Basilico

Cytokine Growth Factor Rev· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Alka Mansukhani, Davide Ambrosetti, Greg Holmes, Lizbeth Cornivelli, Claudio Basilico

J Cell Biol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.
Rossella Di Giaimo, Massimo Riccio, Spartaco Santi, Cesira Galeotti, Davide C Ambrosetti

Hum Mol Genet· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis